ArticleResearch square2024

Virus-like particle (VLP)-based vaccine targeting tau phosphorylated at Ser396/Ser404 (PHF1) site outperforms phosphorylated S199/S202 (AT8) site in reducing tau pathology and restoring cognitive deficits in the rTg4510 mouse model of tauopathy.

Jonathan Hulse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.